Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_assertion type Assertion NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_head.
- NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_assertion description "[Dukes stages C and D were more frequent in primary tumors with loss of MSH3 expression (9 of 13), compared with tumors with retained expression (1 of 14; Fisher's exact test, P = 0.001), suggesting that MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_provenance.
- NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_assertion evidence source_evidence_literature NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_provenance.
- NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_assertion SIO_000772 14871813 NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_provenance.
- NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_assertion wasDerivedFrom befree-20140225 NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_provenance.
- NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_assertion wasGeneratedBy ECO_0000203 NP458636.RAkfMnoNfUtE6xqBgkIAsjC_u5nRZ6BXpZlZ82hbVxmAk130_provenance.